What insurance policy changes affect code R06.81?

There are 4 tracked policy changes affecting code R06.81, including updates from Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code R06.81?

Payers that have issued tracked updates for code R06.81 include: Aetna.

How do I get notified when code R06.81 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code R06.81. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code R06.81?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

PAYER POLICY CHANGES

R06.81 Insurance Policy Changes

ICD-10 R06.81 is officially defined as "Apnea, not elsewhere classified." code R06.81 is referenced in 4 tracked payer policy changes from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code R06.81 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Aetna · Identified Aug 18, 2026Medium impact
Holter Monitors (CPB 0019, reviewed 2026-03-13)
Aetna considers Holter monitoring medically necessary for diagnostic evaluation of adult members with listed conditions, including palpitations, syncope or near syncope, unexplained dizziness, and possible or documented long QT syndrome, and for asymptomatic congenital complete atrioventricular block in pediatric patients. Holter monitoring is considered experimental, investigational, or unproven for all other indications because its effectiveness for those indications has not been established. CPT codes 93224, 93225, 93226 and 93227 are covered if the selection criteria are met.
Aetna · Identified Aug 17, 2026Medium impact
Apnea Monitors for Infants (CPB 0003, reviewed 2026-03-05)
Aetna considers apnea monitors medically necessary durable medical equipment for infants less than 12 months of age with documented apnea or known risk factors for life-threatening apnea. Covered indications include pertussis with positive cultures, documented apnea with bradycardia below 80 beats per minute, marked hypotonia, oxygen desaturation below 90 percent, cyanosis or pallor, gastro-esophageal reflux causing apnea, bradycardia or desaturation, and prolonged apnea of greater than 20 seconds. Infant apnea monitors for all other indications are considered experimental, investigational, or unproven.
Aetna · Identified Aug 14, 2026Medium impact
Pulse Oximetry and Capnography for Home Use (CPB 0339, reviewed 2026-05-21)
Aetna covers home pulse oximetry as durable medical equipment for members with chronic lung disease, severe cardiopulmonary disease, or neuromuscular disease involving the muscles of respiration, when the device is used to determine home oxygen liter flow for ambulation, exercise, or sleep, to monitor a person on a home ventilator, for short-term (one month) monitoring when a physician-directed change in home oxygen liter flow is needed, when weaning from home oxygen, or for interstage monitoring of children undergoing the Norwood procedure for hypoplastic left heart syndrome. Capnography (end-tidal carbon dioxide monitoring) is covered for members with congenital central alveolar hypoventilation syndrome. Home pulse oximetry is considered experimental, investigational, or unproven for asthma management, for evaluating and teaching CPAP, for maintenance or continuous monitoring other than for persons on a ventilator, for predicting the need for adenotonsillectomy in children, and when used alone as a screening or testing technique for suspected obstructive sleep apnea.
Aetna · Identified Aug 12, 2026Medium impact
Acoustic Pharyngometers and SNAP Testing System (CPB 0336, reviewed 2026-05-20)
Aetna considers SNAP Testing using 3 or more channels a medically necessary device for home diagnosis of obstructive sleep apnea in adults, according to the criteria in CPB 0004, and lists HCPCS G0400, a home sleep test with a type IV portable monitor using a minimum of 3 channels, as covered for adults only when selection criteria are met. Acoustic pharyngometry, such as the Eccovision Acoustic Pharyngometer, and SNAP Testing System versions using fewer than 3 channels are considered experimental, investigational, or unproven for screening, diagnosis, treatment planning, or prediction of surgical success in persons with suspected or known obstructive sleep apnea, and for all other indications. The policy lists no specific CPT or HCPCS code for acoustic pharyngometry.

Watch R06.81

Get one email when a payer policy names R06.81, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Holter Monitors (CPB 0019, reviewed 2026-03-13)

Apnea Monitors for Infants (CPB 0003, reviewed 2026-03-05)

Pulse Oximetry and Capnography for Home Use (CPB 0339, reviewed 2026-05-21)

Acoustic Pharyngometers and SNAP Testing System (CPB 0336, reviewed 2026-05-20)

What insurance policy changes affect code R06.81?

Which payers have updated policy for code R06.81?

How do I get notified when code R06.81 policy changes?

Why do payers change policies for code R06.81?